Local Agent Representation for Medical Device and Drug Products in the Philippines

As your Philippines local agent, we will represent you with the Philippines FDA.

To find out more about the independent third-party system and medical regulations in the Philippines, please contact us to discuss your company’s needs.

A foreign medical company can set up its own subsidiary, employ its distributor, or utilize a third-party in-country representative to register their products with the Philippines FDA, a subsection of the Department of Health.

What are the advantages of using a third-party in-country representative in the Philippines?

  • Local Agent Representation for Medical Products in the PhilippinesFor foreign pharmaceutical or medical device companies that do not want to set up a subsidiary or register their products through their Philippine distributor, a third-party in-country representative is the best choice.
  • In the case that you want to transfer your product registration to another distributor in the future, your current distributor holding your product registrations might charge your company a big fee, or refuse to transfer the registration entirely. If a third-party local agent holds your product registration, you can easily switch distributors.
  • The third-party local agent can also be in charge of notifying the Philippines FDA of any changes in your product and overseeing adverse event reporting.

Pacific Bridge Medical can be your company’s in-country representative for registering your pharmaceutical products or medical devices in the Philippines. To find out more about the independent third-party system and medical regulations in the Philippines, please contact us to discuss your company’s needs.

Related Resources

Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.

Related News Briefs

Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.